Technology Review - Published By MIT
Advertisement

TR Editors' blog

Insights, opinions, and our editors' analysis of the latest in emerging technologies.

Blog Topics

Recent Posts

Recent Comments

  • jmaximus9 : The only thing this will do is send the last vestige of American manufacturing to China and...
  • gognod : Why should an employee have to spend an extra 2.5 hours a week at the office and not get paid for...
  • chir0pter : hahahaha
  • jjbaulikki : "While cautioning that the Berlin case could be a fluke" well of course it could be a Fluke
  • plasticdoc : Even though US politicians are aware of European failures in similar policies,they will repeat...
  • Siroilas : I hope you were not serious about altering the gene expression of animals just to create more...
  • danbloom : Do we need a new word for the kind of reading we do on a screen?  by Danny Bloom OPED  "Do we...
  • ... : Hopefully the use of composites in structural elements is not a mistake, but thanks for catching...
  • ... : although the 787 is the first to use composites for a majority of the critical aircraft surfaces...
  • rttedrow : That's a little too aggressive for me; too much road rage and too many drivers packing "heat." ...
Advertisement
Wednesday, January 07, 2009

A Tasty Molecular Clue to Better Drugs

A natural flavor-enhancing mechanism could improve drug delivery.
By Katherine Bourzac

The savory flavor that makes it hard to stop eating flamin' hot Cheetos could perhaps hold the key to delivering drugs more effectively.

Our tongues find this flavor, called umami, in protein-rich foods; it's actually a response to glutamate (or glutamic acid). Dubbed the "fifth taste" (in addition to sour, salty, sweet, and bitter), umami was named by a Japanese scientist in 1908 and has come to prominence in the American consciousness more recently (it's now being used to advertise soy sauce).

Now a California food-science company called Senomyx has uncovered the molecular mechanism that helps enhance umami flavor, and the discovery could not only lead to new flavor enhancers, but also help drug companies looking for molecules to deliver drugs more effectively.

As the researchers describe in the Proceedings of the National Academy of Sciences, a molecule that enhances the umami flavor--ribonucleotide inosine monophosphate--binds along with glutamate to two different targets on a common-type cell receptor called a GPCR (G protein-coupled receptor). The double binding helps enhance the signal.

Since GPCRs are implicated in many diseases and are the target of half of all drugs on the market, understanding this double binding could lead to drug combinations that work better at lower doses.

Advertisement

Comments

Advertisement

Log In

Forgot your password?     Register »
Advertisement
Technology Review July/August 2009

Current Issue

Search Me
Inside the launch of Stephen Wolfram’s new “computational knowledge engine.”
•  Subscribe
Save 41%
•  Table of Contents
•  MIT News
» Gift Subscription
» Digital Subscription
» Reprints, Back Issues
» Subscribe
» Table of Contents
» MIT News

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.